Exclusive

Publication

Byline

Singapore Clinical Trial: A Phase 2/3 Randomized Study to Evaluate the Safety, Efficacy, and Optimal Dose of Telisotuzumab Adizutecan in Combination with Osimertinib as First-Line Treatment in Patients with Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

Singapore, April 5 -- The Health Sciences Authority received information related to the study titled 'A Phase 2/3 Randomized Study to Evaluate the Safety, Efficacy, and Optimal Dose of Telisotuzumab A... Read More


Singapore Clinical Trial: A Study to Evaluate the Effect of Fasting Duration and Temporary Withholding of Tirzepatide on Retained Gastric Contents Using Gastric Ultrasound in Participants with Type 2 Diabetes Mellitus and Participants with Overweight or Obesity without Type 2 Diabetes Mellitus.

Singapore, April 5 -- The Health Sciences Authority received information related to the study titled 'A Study to Evaluate the Effect of Fasting Duration and Temporary Withholding of Tirzepatide on Ret... Read More


Singapore Clinical Trial: A Phase 1/2 Open-Label, Umbrella Platform Design Study of Investigational Agents in Combination With Pembrolizumab (MK-3475) With or Without Chemotherapy in Participants With 1L Locally Advanced Unresectable/Metastatic Esophageal Cancer: KEYMAKER-U06 Substudy 06E

Singapore, April 5 -- The Health Sciences Authority received information related to the study titled 'A Phase 1/2 Open-Label, Umbrella Platform Design Study of Investigational Agents in Combination Wi... Read More


Singapore Clinical Trial: EASi-PROTKT™ - A Phase III double-blind, randomised, parallel-group superiority trial to evaluate efficacy and safety of the combined use of oral vicadrostat (BI 690517) and empagliflozin compared with placebo and empagliflozin in participants with type 2 diabetes, hypertension and established cardiovascular disease

Singapore, April 5 -- The Health Sciences Authority received information related to the study titled 'EASi-PROTKT™ - A Phase III double-blind, randomised, parallel-group superiority trial to evaluate ... Read More


Double the sushi, double the joy: Sushiro confirms two new outlets in PJ and Sunway

PETALING JAYA, April 5 -- Get your sushi belts ready, Klang Valley residents. Japan's beloved conveyor belt giant, Sushiro, is about to double its footprint in the city. After the massive success of ... Read More


CIS Defense Ministers meet in Moscow to discuss Eurasian security and military cooperation

Kyrgyzstan, April 5 -- Moscow hosted a regular meeting of the Council of Defense Ministers of the CIS member states, where Defense Ministers reviewed pressing issues of multilateral military cooperati... Read More


शराब के नशे में छत से गिरा युवक, गई जान

उरई, अप्रैल 5 -- कदौरा। कदौरा थाना क्षेत्र के कानाखेड़ा में शनिवार रात शराब पीकर गाली-गलौज कर रहे युवक का छत से पैर फिसल गया। इससे वह सड़क पर गिर गया। लहूलुहान हालात में परिजन उसे सीएचसी ले कर गए जहां ग... Read More


जिला जज ने कारागार में डिजिटल लाइब्रेरी का उद्घाटन

सुल्तानपुर, अप्रैल 5 -- सुलतानपुर। जिला कारागार अमहट में रविवार को जिला जज ने डिजिटल लाइब्रेरी का उद्घाटन किया। जिला जज ने कहा कि डिजिटल लाइब्रेरी के हो जाने से बंदियों और कैदियों को बेहतर जानकारी प्र... Read More


डीएसपी का सरकारी मोबाइल नम्बर हैंक कर ठगी की कोशिश

समस्तीपुर, अप्रैल 5 -- विद्यापतिनगर। दलसिंहसराय डीएसपी विवेक कुमार शर्मा का सरकारी मोबाइल नंबर हैंक कर रुपया ठगी करने की मामला प्रकाश में आया है। बताया गया है कि उनके सरकारी मोबाइल पर मीडिया कर्मियों ... Read More


'Picture abhi baaki hai': Raghav Chadha hits back at AAP, shares Rajya Sabha speeches on Punjab

New Delhi, April 5 -- Rajya Sabha MP Raghav Chadha on Sunday stepped up his attack on the Aam Aadmi Party, sharing clips of his speeches in the Upper House in which he raised issues concerning Punjab.... Read More